Duarte D, Lima MB, Sepodes B. (2020) The translational value of animal models in orphan medicines designations for rare pediatric neurological diseases
Sheean M, Malikova E, Duarte D, et al. (2019) Nonclinical data supporting orphan medicinal product designations in the area of rare infectious diseases, Drug Discovery Today DOI: 10.1016/j.drudis.2019.10.015
Van der Laan J, Duarte D, et al. (2019) Evaluation of juvenile animal studies for paediatric CNS-targeted compounds; a regulatory perspective, International Journal of Toxicology, Vol 38, issue 6 (456-475) DOI:10.1177/1091581819883569
Hoppu K, Fonseca H. (2021) Why are certain age bands used for children in paediatric studies of medicines? 106 (7): 631- 635. doi: 10.1136/archdischild-2020-319019
Fonseca H., Durão V. (1990) Importância da Farmacocinética em Pediatria
Duarte D, Fonseca H (2008) Melhores medicamentos em Pediatria 39 (1): 17-22
NA (NA) NA https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2007:324:0121:0137:en:PDF# https://www.ema.europa.eu/en/human-regulatory/overview/paediatricmedicines/paediatric-regulation# https://www.ema.europa.eu/en/pharmaceutical-development-medicines-use-older-population#https://www.ema.europa.eu/en/human-regulatory/researchdevelopment/medicines-older-people